Antioxidant Flavonols Associated With Slower Memory Decline
Consuming food and beverages containing flavonols might help to slow the rate of cognitive decline, researchers from Rush University suggest.
Psilocybin and Psychotherapy Relieve Treatment-Resistant Depression in Largest Clinical Trial to Date
The largest study to date testing the ability of the psychedelic compound psilocybin to treat a psychiatric disorder has shown that the mushroom-derived drug, delivered in combination with integrative psychotherapy sessions, significantly reduced participants’ depression as compared to a placebo after three weeks.
Researcher Unveils World's Largest Drug Database
DrugBank contains detailed chemical, pharmaceutical, medical and molecular biological information on 3000 drug targets.
Scynexis Europe is now Selcia Following Spin off from Scynexis Inc.
Selcia will offer new services such as metabolomics and metabolic profiling, and their integration with chemistry.
XDX Named 2006 Technology Pioneer by World Economic Forum
XDx names Technology Pioneer to develop and commercialize practical applications built on insights from the Human Genome Project.
Sangamo Announces Expansion of Research Collaboration Agreement with Pfizer
Sangamo will use its ZFP technology to develop cell lines for enhanced protein production.
Oxford Gene Technology Appoints Research and Development Director
Dr John Anson joins OGT after 16 years at Amersham Biosciences/GE Healthcare.
Little Known DNA Repair Enzyme may be a Tumor Suppressor Gene
Pol zeta has the ability to give cells with even heavily damaged DNA a new lease on life.
Kalypsys Announces Small Molecule Research Collaboration with Alcon
Kalypsys will use its uHTS technology and chemical library to identify and profile active molecules against collaboration targets.
Imaging Study Links Key Genetic Risk for Alzheimer's Disease to Myelin Breakdown
Findings shows that myelin breakdown is a key contributor to the onset of Alzheimer disease.
Exiqon Appoints President and General Manager of new US Operations
Michael Kallelis will have the overall responsibility for launching and operating Exiqon’s US office to be located in the Boston area.
Epitome to Develop Biomarker Assay Panels for Bristol-Myers Squibb
Epitome will develop custom antibody arrays for quantitative and high throughput measurement of proteins specified by Bristol-Myers.